Cardiovascular-Kidney-Metabolic Syndrome: Development of an ICD-10-CM Coding Framework.

IF 2.9 Q2 Medicine
JMIR Diabetes Pub Date : 2026-04-12 DOI:10.2196/91827
Minzhe Zhao, Junhao Zhang, Huiyun Wang, Chongjun Xu, Jiahui Li, Chenghua Li, Xuemei He, Xueying Zheng
{"title":"Cardiovascular-Kidney-Metabolic Syndrome: Development of an ICD-10-CM Coding Framework.","authors":"Minzhe Zhao, Junhao Zhang, Huiyun Wang, Chongjun Xu, Jiahui Li, Chenghua Li, Xuemei He, Xueying Zheng","doi":"10.2196/91827","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular-Kidney-Metabolic (CKM) syndrome is a multisystem construct describing the intertwined progression of cardiometabolic risk factors, chronic kidney disease (CKD), and cardiovascular disease (CVD). The American Heart Association (AHA) proposed CKM stages (0-4) for risk stratification and prevention. However, CKM lacks a single ICD-10-CM code, which hinders standardized stage identification in EHRs and claims data.</p><p><strong>Objective: </strong>To develop an AHA-aligned ICD-10-CM coding framework as an implementation template that operationalizes CKM stages 0-4 for reproducible cohort identification and stage-based analyses in real-world data.</p><p><strong>Methods: </strong>We mapped American Heart Association CKM stages (0-4) to ICD-10-CM diagnosis code sets using FY2026 conventions, code-set engineering best practices, and clinician review. To improve reproducibility, we defined a hierarchical staging algorithm, co-occurrence rules, and recommended lookback and encounter-confirmation thresholds. Stage 3 includes guidance for EHR-enhanced ascertainment and claims-only proxies.</p><p><strong>Results: </strong>We provide stage-specific ICD-10-CM code sets for CKM stages 0-4. Stage 1 captures excess or dysfunctional adiposity or prediabetes. Stage 2 captures established metabolic disease and earlier-stage CKD. Stage 3 captures subclinical cardiovascular injury or very high-risk CKD. Stage 4 captures overt clinical CVD events, with or without kidney failure.</p><p><strong>Conclusions: </strong>This implementation framework enables transparent, reproducible CKM staging in real-world datasets and supports stage-based epidemiologic and health-system applications. Empirical validation and local implementation testing are needed prior to clinical deployment.</p><p><strong>Clinicaltrial: </strong></p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2026-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JMIR Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2196/91827","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cardiovascular-Kidney-Metabolic (CKM) syndrome is a multisystem construct describing the intertwined progression of cardiometabolic risk factors, chronic kidney disease (CKD), and cardiovascular disease (CVD). The American Heart Association (AHA) proposed CKM stages (0-4) for risk stratification and prevention. However, CKM lacks a single ICD-10-CM code, which hinders standardized stage identification in EHRs and claims data.

Objective: To develop an AHA-aligned ICD-10-CM coding framework as an implementation template that operationalizes CKM stages 0-4 for reproducible cohort identification and stage-based analyses in real-world data.

Methods: We mapped American Heart Association CKM stages (0-4) to ICD-10-CM diagnosis code sets using FY2026 conventions, code-set engineering best practices, and clinician review. To improve reproducibility, we defined a hierarchical staging algorithm, co-occurrence rules, and recommended lookback and encounter-confirmation thresholds. Stage 3 includes guidance for EHR-enhanced ascertainment and claims-only proxies.

Results: We provide stage-specific ICD-10-CM code sets for CKM stages 0-4. Stage 1 captures excess or dysfunctional adiposity or prediabetes. Stage 2 captures established metabolic disease and earlier-stage CKD. Stage 3 captures subclinical cardiovascular injury or very high-risk CKD. Stage 4 captures overt clinical CVD events, with or without kidney failure.

Conclusions: This implementation framework enables transparent, reproducible CKM staging in real-world datasets and supports stage-based epidemiologic and health-system applications. Empirical validation and local implementation testing are needed prior to clinical deployment.

Clinicaltrial:

心血管-肾-代谢综合征:ICD-10-CM编码框架的建立
背景:心血管-肾-代谢(CKM)综合征是一个多系统结构,描述了心血管代谢危险因素、慢性肾脏疾病(CKD)和心血管疾病(CVD)相互交织的进展。美国心脏协会(AHA)提出CKM分期(0-4)进行风险分层和预防。然而,CKM缺乏单一的ICD-10-CM代码,这阻碍了电子病历和索赔数据的标准化阶段识别。目的:开发一个与aha一致的ICD-10-CM编码框架,作为实施模板,将CKM 0-4期进行可重复的队列识别和基于阶段的现实世界数据分析。方法:我们使用FY2026惯例、代码集工程最佳实践和临床医生审查,将美国心脏协会CKM分期(0-4)映射到ICD-10-CM诊断代码集。为了提高再现性,我们定义了分层分期算法、共现规则,并推荐了回溯和相遇确认阈值。第3阶段包括对ehr加强的确定和仅索赔代理的指导。结果:我们为CKM 0-4期提供了阶段性的ICD-10-CM代码集。第一阶段是过度或功能失调的肥胖或前驱糖尿病。阶段2捕获已确定的代谢性疾病和早期CKD。第三阶段是亚临床心血管损伤或高危CKD。第4期捕获明显的临床CVD事件,伴或不伴肾衰竭。结论:该实施框架在真实世界数据集中实现了透明、可重复的CKM分期,并支持基于分期的流行病学和卫生系统应用。在临床部署之前,需要进行经验验证和本地实施测试。临床试验:
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
JMIR Diabetes
JMIR Diabetes Computer Science-Computer Science Applications
CiteScore
4.00
自引率
0.00%
发文量
35
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书